G Square announced it will acquire a majority stake in Serres, the Finnish medtech firm that designs sustainable surgical fluid management tools. The deal follows Serres' €38m turnover in 2024 and positions the buyer to expand its footprint in the growing global surgical technology market.

The transaction, expected to close in Q1 2026, will leave Paree Group with a significant stake, preserving a link to the family‑owned company headquartered in Kauhajoki. Investors will watch how the integration could boost product pipelines and scale distribution across Europe and North America.

G Square's move signals a broader trend of consolidation in medtech, as firms seek to combine complementary technologies and accelerate market entry. Analysts expect the acquisition to generate synergies in R&D and supply chain efficiencies, potentially driving higher margins for both parties in the next fiscal cycle.

Stakeholders will also monitor regulatory approvals, as the acquisition crosses EU and US jurisdictions. If cleared, the deal could set a precedent for future cross‑border investments in sustainable medical devices, encouraging other private‑equity players to target niche, high‑growth segments globally.